It's time to complete your JBC Methods Madness bracket
Calling all scientists! Do you have a favorite method? Is there a biochemical technique you think has had monumental impacts on basic research and deserves a moment in the spotlight? The Journal of Biological Chemistry’s Methods Madness tournament is the chance you’ve been waiting for to voice your opinions. The person with the top-scoring bracket will win a $50 gift card.
How to participate
- Download and fill in your bracket. Use the editable PDF to make your predictions. Save your changes!
- Email your bracket to JBC. Double-check your entry, and then email it to methods@asbmb.org.
- Follow JBC on Twitter and vote for your favorite methods. The JBC Twitter handle is @JBiolChem. They'll be posting weekly polls. Don't forget to participate.
Visit the JBC Methods Madness website for the complete rules.
A note about JBC methods
It's well known that science progresses by building on the shoulders of those who came before. That's especially true for papers that report new tools — genetic constructs, small molecules, model organisms, etc. — that can be directly used by colleagues to jump-start a new project or resolve a technical hurdle. And at JBC, our high standards for rigor and reproducibility mean that readers can trust published tools to work as promised.
— Lila Gierasch, JBC editor-in-chief
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.
Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.
Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.
Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.
Cracking cancer’s code through functional connections
A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.
Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.